Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trialsReich, Kristian, Prof ; Papp, Kim A, MD ; Blauvelt, Andrew, MD ; Tyring, Stephen K, Prof ; Sinclair, Rodney, Prof ; Thaçi, Diamant, Prof ; Nograles, Kristine, MD ; Mehta, Anish, BA ; Cichanowitz, Nicole, MSJ ; Li, Qing, PhD ; Liu, Kenneth, PhD ; La Rosa, Carmen, MD ; Green, Stuart, MD ; Kimball, Alexa B, ProfThe Lancet (British edition), 2017-07, Vol.390 (10091), p.276-288 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Treatment of hidradenitis suppurativa with biologic medicationsLee, Robert A., MD, PhD ; Eisen, Daniel B., MDJournal of the American Academy of Dermatology, 2015-11, Vol.73 (5), p.S82-S88 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)Blauvelt, Andrew ; Gooderham, Melinda ; Iversen, Lars ; Ball, Susan ; Zhang, Lu ; Agada, Noah O. ; Reich, KristianJournal of the American Academy of Dermatology, 2017-11, Vol.77 (5), p.855-862 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trialsSpencer, Riley K. ; Jin, Joy Q. ; Elhage, Kareem G. ; Davis, Mitchell S. ; Hakimi, Marwa ; Bhutani, Tina ; Liao, WilsonJournal of the American Academy of Dermatology, 2023-08, Vol.89 (2), p.423-425 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trialPorter, Duncan, Dr ; van Melckebeke, Jurgen, BSc ; Dale, James, PhD ; Messow, C Martina, PhD ; McConnachie, Alexander, PhD ; Walker, Andrew, PhD ; Munro, Robin, MRCP ; McLaren, John, MRCP ; McRorie, Euan, FRCP ; Packham, Jon, DM ; Buckley, Christopher D, Prof ; Harvie, John, FRCP ; Taylor, Peter, Prof ; Choy, Ernest, Prof ; Pitzalis, Costantino, Prof ; McInnes, Iain B, ProfThe Lancet (British edition), 2016-07, Vol.388 (10041), p.239-247 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysisLoos, Anne M. ; Liu, Shanshan ; Segel, Celia ; Ollendorf, Daniel A. ; Pearson, Steven D. ; Linder, Jeffrey A.Journal of the American Academy of Dermatology, 2018-07, Vol.79 (1), p.135-144.e7 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsGriffiths, Christopher E M, Prof ; Reich, Kristian, Prof ; Lebwohl, Mark, Prof ; van de Kerkhof, Peter, Prof ; Paul, Carle, Prof ; Menter, Alan, MD ; Cameron, Gregory S, PhD ; Erickson, Janelle, PhD ; Zhang, Lu, MS ; Secrest, Roberta J, PhD ; Ball, Susan, PhD ; Braun, Daniel K, MD ; Osuntokun, Olawale O, MD ; Heffernan, Michael P, MD ; Nickoloff, Brian J, MD ; Papp, Kim, MDThe Lancet (British edition), 2015-08, Vol.386 (9993), p.541-551 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Strober, Bruce E., MD, PhD ; Bissonnette, Robert, MD ; Fiorentino, David, MD, PhD ; Kimball, Alexa B., MPH, MD ; Naldi, Luigi, MD ; Shear, Neil H., MD ; Goyal, Kavitha, MD ; Fakharzadeh, Steven, MD, PhD ; Calabro, Stephen, MS ; Langholff, Wayne, PhD ; You, Yin, MS ; Galindo, Claudia, MD ; Lee, Seina, MS, PharmD ; Lebwohl, Mark G., MDJournal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.851-861.e4 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanerceptYang, A. ; Xin, X. ; Yang, W. ; Li, M. ; Li, L. ; Liu, X.Annales de dermatologie et de vénéréologie, 2019-05, Vol.146 (5), p.363-371 [Periódico revisado por pares]France: Elsevier Masson SASTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitisBaraliakos, Xenofon ; Szumski, Annette ; Koenig, Andrew S. ; Jones, HeatherSeminars in arthritis and rheumatism, 2019-06, Vol.48 (6), p.997-1004 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |